Evolution of novel, orally efficacious renin inhibitors: A topographical design approach towards Aliskiren.

被引:0
|
作者
Maibaum, J [1 ]
机构
[1] Novartis Pharma AG, Novartis Inst Biomed Res Basel, CH-4002 Basel, Switzerland
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 226卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
50-MEDI
引用
收藏
页码:U9 / U9
页数:1
相关论文
共 50 条
  • [31] Structure based design and synthesis of novel orally active thrombin inhibitors
    Haramura, M
    Shiraishi, T
    Haneishi, T
    Kuromaru, K
    Ohta, M
    Kim, JM
    Nam, WH
    Jung, KY
    Jeon, GH
    Kozono, T
    PEPTIDE SCIENCE - PRESENT AND FUTURE, 1999, : 639 - 641
  • [32] Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients
    Gradman, AH
    Schmieder, RE
    Lins, RL
    Nussberger, J
    Chiang, YT
    Bedigian, MP
    CIRCULATION, 2005, 111 (08) : 1012 - 1018
  • [33] Structure-Based Design of Substituted Piperidines as a New Class of Highly Efficacious Oral Direct Renin Inhibitors
    Ehara, Takeru
    Irie, Osamu
    Kosaka, Takatoshi
    Kanazawa, Takanori
    Breitenstein, Werner
    Grosche, Philipp
    Ostermann, Nils
    Suzuki, Masaki
    Kawakami, Shimpei
    Konishi, Kazuhide
    Hitomi, Yuko
    Toyao, Atsushi
    Gunji, Hirold
    Cumin, Frederic
    Schiering, Nikolaus
    Wagner, Trixie
    Rigel, Dean F.
    Webb, Randy L.
    Maibaum, Juergen
    Yokokawa, Fumiaki
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (07): : 787 - 792
  • [34] 3-DIMENSIONAL STRUCTURE OF HUMAN RENIN AND RENIN INHIBITORS - NEW APPROACH TO DRUG DESIGN
    AKAHANE, K
    NAKAGAWA, S
    UMEYAMA, H
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1985, 8 (07): : S174 - S174
  • [35] Aliskiren, a novel, orally effective nonpeptide renin inhibitor, lowers blood pressure after once-daily dosing in marmosets, rats and humans
    Wood, JM
    Webb, RL
    Cumin, F
    Schnell, CR
    Bedigian, MP
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 481A - 482A
  • [36] A Novel approach towards Drug Design
    Sika-Paotonu, Dianne
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [37] Discovery of atrop fixed alkoxy-aminobenzhydrol derivatives: Novel, highly potent and orally efficacious squalene synthase inhibitors
    Ichikawa, Masanori
    Yokomizo, Aki
    Itoh, Masao
    Haginoya, Noriyasu
    Sugita, Kazuyuki
    Usui, Hiroyuki
    Terayama, Koji
    Kanda, Akira
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (17) : 5207 - 5224
  • [38] Discovery of atrop fixed alkoxy-aminobenzhydrol derivatives: Novel, highly potent and orally efficacious squalene synthase inhibitors
    Ichikawa, Masanori
    Yokomizo, Aki
    Itoh, Masao
    Haginoya, Noriyasu
    Sugita, Kazuyuki
    Usui, Hiroyuki
    Terayama, Koji
    Kanda, Akira
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [39] Design, synthesis, and structure-activity relationship of novel orally efficacious pyrazole/sulfonamide based dihydroquinoline γ-secretase inhibitors (vol 19, pg 4920, 2009)
    Truong, Anh P.
    Aubele, Danielle L.
    Probst, Gary D.
    Neitzel, Martin L.
    Semko, Chris M.
    Bowers, Simeon
    Dressen, Darren
    Hom, Roy K.
    Konradi, Andrei W.
    Sham, Hing L.
    Garofalo, Albert W.
    Keim, Pamela S.
    Wu, Jing
    Dappen, Michael S.
    Wong, Karina
    Goldbach, Erich
    Quinn, Kevin P.
    Sauer, John-Michael
    Brigham, Elizabeth F.
    Wallace, William
    Nguyen, Lan
    Hemphill, Susanna S.
    Bova, Michael P.
    Bard, Frederique
    Yednock, Ted A.
    Basi, Guriqbal
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7553 - 7553
  • [40] Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: Design, synthesis, and preclinical characterization
    Elokdah, H
    Abou-Gharbia, M
    Hennan, JK
    McFarlane, G
    Mugford, CP
    Krishnamurthy, G
    Crandall, DL
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (14) : 3491 - 3494